IL1B and Alzheimer disease: Serum IL-1β levels in AD patients (0.43 / 0.23–0.61 pg/ml) showed no differences compared to control subjects (0.42 / 0.21–0.77 pg/ml; p = 0.81) (Fig. 2a).